A PHASE IV MULTICENTER, OPEN-LABEL STUDY EVALUATING B CELL LEVELS IN INFANTS POTENTIALLY EXPOSED TO OCRELIZUMAB DURING PREGNANCY - THE MINORE STUDY

This Study is
No Longer Enrolling

Details
Age

Child to Adult

Type of Study

Outcomes Research

Locations

Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 22-0386

More information available at ClinicalTrials.gov: NCT04998812

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers